Association of plasma MIR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report

Platelets

Volumn 26, Issue 6, 2015, Pages 593-597

  Chyrchel, Bernadeta ^a,b   Totoń Zurańska, Justyna ^a   Kruszelnicka, Olga ^c   Chyrchel, Michał ^b   Mielecki, Waldemar ^b   Kołton Wróz, Maria ^a   Wołkow, Paweł ^a   Surdacki, Andrzej ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^c Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

Clopidogrel; coronary artery disease; MIR 223; platelet reactivity; prasugrel; ticagrelor

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; MICRORNA 16; MICRORNA 223; PRASUGREL; TICAGRELOR; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; MICRORNA; MIRN223 MICRORNA, HUMAN; TICLOPIDINE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; LOADING DRUG DOSE; LOW DRUG DOSE; MALE; MORNING DOSAGE; PLATELET REACTIVITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; AGED; ANALOGS AND DERIVATIVES; BLOOD; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; THROMBOCYTE; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME;

AGED; ASPIRIN; BIOMARKERS; BLOOD PLATELETS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84938585111     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2014.974527     Document Type: Article

References (23)

1. Diehl P, Fricke A, Sander L, Stamm J, Bassler N, Htun N, Ziemann M, Helbing T, El-Osta A, Jowett JB, et al. Microparticles: Major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 2012;93:633-644.
2. Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard JM, Mayr A, Weger S, Schett G, Shah A, et al. Prospective study on circulating microRNAs and risk of myocardial infarction. J Am Coll Cardiol 2012;60:290-299.
3. Willeit P, Zampetaki A, Dudek K, Kaudewitz D, King A, Kirkby NS, Crosby-Nwaobi R, Prokopi M, Drozdov I, Langley SR, et al. Circulating microRNAs as novel biomarkers for platelet activation. Circ Res 2013;112:595-600.
4. Laffont B, Corduan A, Plé H, Duchez AC, Cloutier N, Boilard E, Provost P. Activated platelets can deliver mRNA regulatory Ago2 microRNA complexes to endothelial cells via microparticles. Blood 2013;122:253-261.
5. Landry P, Plante I, Oullet DL, Perron MP, Rousseau G, Provost P. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 2009;19:961-966.
6. Warshaw AL, Laster L, Shulman NR. Protein synthesis by human platelets. J Biol Chem 1967;242:2094-2097.
7. Shi R, Ge L, Zhou X, Ji WJ, Lu RY, Zhang YY, Zeng S, Liu X, Zhao JH, Zhang WC, et al. Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity. Thromb Res 2013;131:508-513.
8. Zhang YY, Zhou X, Ji WJ, Shi R, Lu RY, Li JL, Yang GH, Luo T, Zhang JQ, Zhao JH, et al. Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome. J Thromb Thrombolysis 2014;38:65-72.
9. Matetzky S, Shenkman B, Guetta V, Shechter M, Beinart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004;109:3171-3175.
10. Zampetaki A, Diehl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010;107:810-817.
11. Duan X, Zhan Q, Song B, Zeng S, Zhou J, Long Y, Lu J, Li Z, Yuan M, Chen X, et al. Detection of platelet microRNA expression in patients with diabetes mellitus with or without ischemic stroke. J Diabetes Complications 2014;38:705-710.
12. Badrnya S, Baumgartner R, Assinger A. Smoking alters circulating plasma microvesicle pattern and microRNA signatures. Thromb Haemost 2014;112:128-136.
13. Chyrchel B, Surdacki A, Chyrchel M, Dudek D, Dubiel JS. Separate dosing of clopidogrel and omeprazole may improve platelet inhibition on dual antiplatelet therapy. Int J Cardiol 2011;149: 124-125.
14. Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schömig A, Kastrati A, von Beckerath N. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008;99:121-126.
15. Siller-Matula JM, Christ G, Lang IM, Delle-Karth G, Huber K, Jilma B. Multiple electrode aggregometry better predicts stent thrombosis than the VASP assay. J Thromb Haemost 2010;8: 351-359.
16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro III AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. ; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
17. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-2015.
18. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-1057.
19. Yu XY, Chen JY, Zheng ZW, Wu H, Li LW, Zhang ZW, Chen ZH, Lin QX, Han YL, Zhong SL. Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention. EuroIntervention 2013;9:546-554.
20. Leierseder S, Petzold T, Zhang L, Loyer X, Massberg S, Engelhardt S. MiR-223 is dispensable for platelet production and function in mice. Thromb Haemost 2013;110:1207-1214.
21. Edelstein LC, Simon LM, Montoya RT, Holinstat M, Chen ES, Bergeron A, Kong X, Nagalla S, Mohandas N, Cohen DE, et al. Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c. Nat Med 2013;19:1609-1616.
22. Paarup Dridi N, Johansson PI, Lønborg JT, Clemmensen P, Radu MD, Qayyum A, Pedersen F, Kollslid R, Helqvist S, Saunamäki K, et al. Tailored antiplatelet therapy to improve prognosis in patients exhibiting clopidogrel low-response prior to percutaneous coronary intervention for stable angina or non-ST elevation acute coronary syndrome. Platelets 2014; e-pub 28. 08. 2014. [Epub ahead of print]. doi: 10. 3109/09537104. 2014. 948837.
23. Cheng HH, Yi HS, Kim Y, Kroh EM, Chien JW, Eaton KD, Goodman MT, Tait JF, Tewari M, Pritchard CC. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One 2013;8:e64795.